Hong Kong · Delayed Price · Currency is HKD PegBio Statistics
Total Valuation
PegBio has a market cap or net worth of HKD 2.30 billion. The enterprise value is 2.01 billion.
| Market Cap | 2.30B |
| Enterprise Value | 2.01B |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PegBio has 391.09 million shares outstanding. The number of shares has increased by 5.49% in one year.
| Current Share Class | 284.30M |
| Shares Outstanding | 391.09M |
| Shares Change (YoY) | +5.49% |
| Shares Change (QoQ) | +1.22% |
| Owned by Insiders (%) | 22.67% |
| Owned by Institutions (%) | 18.15% |
| Float | 151.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 7.47 |
| P/TBV Ratio | 7.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.57.
| Current Ratio | 2.56 |
| Quick Ratio | 2.29 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -98.70 |
Financial Efficiency
Return on equity (ROE) is -125.57% and return on invested capital (ROIC) is -51.76%.
| Return on Equity (ROE) | -125.57% |
| Return on Assets (ROA) | -44.55% |
| Return on Invested Capital (ROIC) | -51.76% |
| Return on Capital Employed (ROCE) | -97.15% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -6.59M |
| Employee Count | 53 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.18% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -83.18% |
| 50-Day Moving Average | 6.04 |
| 200-Day Moving Average | 38.95 |
| Relative Strength Index (RSI) | 44.68 |
| Average Volume (20 Days) | 15,370,701 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -365.21M |
| Pretax Income | -382.21M |
| Net Income | -382.00M |
| EBITDA | -364.21M |
| EBIT | -365.21M |
| Earnings Per Share (EPS) | -0.98 |
Balance Sheet
The company has 471.82 million in cash and 176.21 million in debt, with a net cash position of 295.61 million or 0.76 per share.
| Cash & Cash Equivalents | 471.82M |
| Total Debt | 176.21M |
| Net Cash | 295.61M |
| Net Cash Per Share | 0.76 |
| Equity (Book Value) | 308.06M |
| Book Value Per Share | 0.79 |
| Working Capital | 321.55M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.01M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PegBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.49% |
| Shareholder Yield | -5.49% |
| Earnings Yield | -16.60% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |